Skip to main content
. 2021 Nov 10;13:17588359211056179. doi: 10.1177/17588359211056179

Figure 2.

Figure 2.

Kaplan–Meier estimates for progression-free survival (a) and the overall survival (b) in the intention-to-treat population, progression-free survival (c) and the overall survival (d) in patients with metastatic pancreatic cancer (post hoc analysis).